United States Biotechnology & Medical Research

Forma Therapeutics Holdings Inc (FMTX)

Track

Ticker: FMTX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Sale 23 Feb 2022
Value US$211,169.75 | Price 133.46 | Shares 25,558 (-33.9%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2022-02-25 2022-02-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
25,558 -33.9%
133.46
US$211,170 		25,558 -33.9% 133.46 US$211,170
2022-02-25 2022-02-23 S Sale
Lesser Brian Andrew

SVP, Commercial

Officer
7,809 -29.2%
148.59
US$2,877,986 		7,809 -29.2% 148.59 US$2,877,986
2022-02-25 2022-02-23 S Sale
3.7
Lee Frank D.

President and CEO

Executive Director
695 -35.9%
108.09
US$4,403,049 		695 -35.9% 108.09 US$4,403,049
2022-02-25 2022-02-23 S Sale
Shegog Todd

SVP, Chief Financial Officer

Officer
5,687 -20.0%
9.78
US$55,605 		5,687 -20.0% 9.78 US$55,605
2022-02-25 2022-02-23 S Sale
Kelly Patrick F.

SVP, Chief Medical Officer

Officer
5,245 -7.5%
9.78
US$51,283 		5,245 -7.5% 9.78 US$51,283
2022-02-25 2022-02-23 S Sale
1.8
Potts Jeannette

See Remarks

Officer
4,672 -17.3%
9.78
US$45,680 		4,672 -17.3% 9.78 US$45,680
2022-02-25 2022-02-23 S Sale
COOK DAVID N

SVP, Chief Scientific Officer

Officer
3,531 -17.7%
9.78
US$34,524 		3,531 -17.7% 9.78 US$34,524
2020-06-25 2020-06-23 B Purchase
3.0
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
Large shareholder
1,000,000 +79.8%
20.00
US$20,000,000 		1,000,000 +79.8% 20.00 US$20,000,000
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
Fanucci Marsha
Non-Executive Director
33,781
0.00
US$0 		33,781 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
29,222
0.00
US$0 		29,222 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
23,354
0.00
US$0 		23,354 0.00 US$0
2020-06-24 2020-06-23 S Sale
Wadlinger Mary E.

See Remarks

Officer
91,876
0.00
US$0 		91,876 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
18,585
0.00
US$0 		18,585 0.00 US$0
2020-06-24 2020-06-23 S Sale
0.5
WIRTH PETER
Non-Executive Director
25,756
0.00
US$0 		25,756 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
40,911
0.00
US$0 		40,911 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
5,844
0.00
US$0 		5,844 0.00 US$0
2020-06-24 2020-06-23 S Sale
Kelly Patrick F.

Chief Medical Officer

Officer
17,533
0.00
US$0 		17,533 0.00 US$0
2020-06-24 2020-06-23 B Purchase
2.9
RA CAPITAL MANAGEMENT, L.P.
Large shareholder
4,000,000 +79.8%
20.00
US$80,000,000 		4,000,000 +79.8% 20.00 US$80,000,000
2020-06-24 2020-06-23 S Sale
3.1
CLACKSON TIMOTHY P
Non-Executive Director
35,067
0.00
US$0 		35,067 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
14,026
0.00
US$0 		14,026 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
10,240
0.00
US$0 		10,240 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
9,847
0.00
US$0 		9,847 0.00 US$0
2020-06-24 2020-06-23 S Sale
Paoletti Paolo
Non-Executive Director
25,248
0.00
US$0 		25,248 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Kolchinsky Peter
Non-Executive Director Large shareholder
4,000,000 +79.8%
20.00
US$80,000,000 		4,000,000 +79.8% 20.00 US$80,000,000
2020-06-24 2020-06-23 B Purchase
Kelly Patrick F.

Chief Medical Officer

Officer
42,959
0.00
US$0 		42,959 0.00 US$0
2020-06-24 2020-06-23 B Purchase
0.5
WIRTH PETER
Non-Executive Director
63,299
0.00
US$0 		63,299 0.00 US$0
2020-06-24 2020-06-23 B Purchase
3.1
CLACKSON TIMOTHY P
Non-Executive Director
23,590
0.00
US$0 		23,590 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Wadlinger Mary E.

See Remarks

Officer
115,575
0.00
US$0 		115,575 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Fanucci Marsha
Non-Executive Director
52,532
0.00
US$0 		52,532 0.00 US$0
2020-06-24 2020-06-23 B Purchase
Paoletti Paolo
Non-Executive Director
45,553
0.00
US$0 		45,553 0.00 US$0
Explore more

More insider trading research around Forma Therapeutics Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America